News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
50,444 Results
Type
Article (3178)
Company Profile (43)
Press Release (47223)
Multimedia
Podcasts (4)
Webinars (2)
Section
Business (18028)
Career Advice (96)
Deals (2682)
Drug Delivery (10)
Drug Development (5068)
Employer Resources (11)
FDA (615)
Job Trends (1009)
News (25838)
Policy (1431)
Tag
Academia (222)
Allergies (6)
Alliances (4653)
ALS (4)
Alzheimer's disease (59)
Antibody-drug conjugate (ADC) (18)
Approvals (618)
Artificial intelligence (21)
Autoimmune disease (3)
Automation (1)
Bankruptcy (12)
Best Places to Work (630)
BIOSECURE Act (2)
Biosimilars (12)
Biotechnology (32)
Bladder cancer (7)
Brain cancer (5)
Breast cancer (21)
Cancer (179)
Cardiovascular disease (7)
Career advice (79)
Career pathing (2)
CAR-T (17)
Cell therapy (53)
Cervical cancer (2)
Clinical research (3920)
Collaboration (111)
Company closure (1)
Compensation (52)
COVID-19 (229)
CRISPR (8)
C-suite (37)
Cystic fibrosis (2)
Data (158)
Denatured (3)
Depression (3)
Diabetes (13)
Diagnostics (550)
Digital health (1)
Diversity, equity & inclusion (1)
Drug discovery (15)
Drug pricing (7)
Duchenne muscular dystrophy (12)
Earnings (5151)
Editorial (4)
Employer branding (2)
Employer resources (9)
Events (7603)
Executive appointments (113)
FDA (684)
Funding (106)
Gene editing (19)
Gene therapy (25)
GLP-1 (67)
Government (204)
Guidances (10)
Healthcare (974)
Huntington's disease (3)
IgA nephropathy (4)
Immunology and inflammation (20)
Indications (2)
Infectious disease (241)
Inflammatory bowel disease (11)
Inflation Reduction Act (6)
Influenza (8)
Intellectual property (12)
Interviews (13)
IPO (1200)
IRA (7)
Job creations (379)
Job search strategy (76)
Kidney cancer (4)
Labor market (5)
Layoffs (44)
Leadership (1)
Legal (293)
Liver cancer (9)
Lung cancer (17)
Lymphoma (7)
Machine learning (2)
Management (4)
Manufacturing (29)
MASH (5)
Medical device (597)
Medtech (597)
Mergers & acquisitions (1571)
Metabolic disorders (41)
Multiple sclerosis (10)
Neurodegenerative disease (11)
Neuropsychiatric disorders (3)
Neuroscience (117)
NextGen: Class of 2025 (492)
Non-profit (275)
Now hiring (4)
Obesity (19)
Opinion (23)
Ovarian cancer (11)
Pain (12)
Pancreatic cancer (3)
Parkinson's disease (10)
Partnered (2)
Patents (25)
Patient recruitment (5)
Peanut (1)
People (7113)
Pharmaceutical (7)
Phase I (1685)
Phase II (1926)
Phase III (1016)
Pipeline (131)
Policy (15)
Postmarket research (47)
Preclinical (752)
Press Release (7)
Prostate cancer (3)
Psychedelics (2)
Radiopharmaceuticals (18)
Rare diseases (32)
Real estate (642)
Recruiting (5)
Regulatory (1068)
Reports (7)
Research institute (206)
Resumes & cover letters (11)
RNA editing (1)
Schizophrenia (12)
Series A (33)
Series B (9)
Service/supplier (2)
Sickle cell disease (2)
Special edition (2)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (645)
Stomach cancer (1)
Supply chain (5)
Tariffs (2)
The Weekly (1)
Vaccines (38)
Venture capitalists (8)
Weight loss (14)
Women's health (3)
Worklife (1)
Date
Today (23)
Last 7 days (102)
Last 30 days (333)
Last 365 days (3007)
2025 (1121)
2024 (3152)
2023 (3512)
2022 (4622)
2021 (5036)
2020 (4538)
2019 (3112)
2018 (2344)
2017 (2406)
2016 (2261)
2015 (2549)
2014 (1872)
2013 (1649)
2012 (1833)
2011 (1842)
2010 (1542)
Location
Africa (52)
Alabama (1)
Alaska (1)
Arizona (16)
Asia (2701)
Australia (355)
California (1044)
Canada (149)
China (45)
Colorado (25)
Connecticut (12)
Delaware (6)
Europe (5380)
Florida (69)
Georgia (8)
Idaho (4)
Illinois (20)
India (1)
Indiana (38)
Japan (11)
Kansas (14)
Maryland (50)
Massachusetts (389)
Michigan (15)
Minnesota (23)
Missouri (6)
Nebraska (1)
Nevada (3)
New Hampshire (3)
New Jersey (95)
New York (98)
North Carolina (105)
Northern California (454)
Ohio (30)
Oklahoma (2)
Oregon (5)
Pennsylvania (68)
Rhode Island (4)
South America (57)
South Carolina (1)
Southern California (436)
Tennessee (3)
Texas (88)
United States (2271)
Utah (7)
Virginia (10)
Washington D.C. (2)
Washington State (60)
West Virginia (1)
Wisconsin (6)
50,444 Results for "assembly biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Assembly Biosciences Reports First Quarter 2025 Financial Results and Recent Updates
May 9, 2025
·
8 min read
Press Releases
New Preclinical Data for Assembly Biosciences’ Oral Hepatitis D Virus Entry Inhibitor ABI-6250 and Next-Generation Hepatitis B Virus Capsid Assembly Modulator ABI-4334 Presented at the EASL Congress 2025
May 8, 2025
·
6 min read
Press Releases
Assembly Biosciences Reports Year End 2024 Financial Results and Recent Highlights
March 20, 2025
·
8 min read
Deals
Assembly Biosciences Announces $12.6 Million in Equity Financings
Assembly Biosciences, Inc. today announced that it has closed the issuance of shares of its common stock and warrants to Armistice Capital LLC (“Armistice Capital”), a healthcare-focused institutional investor, and Gilead Sciences, Inc. (“Gilead”), in separate equity financings that have resulted in aggregate gross proceeds to Assembly Bio of approximately $12.6 million, before deducting expenses.
June 17, 2024
·
5 min read
Press Releases
Assembly Biosciences Presents New Data Highlighting Long-Acting Herpes Simplex Virus Candidate ABI-5366 and Genital Herpes Prevalence and Treatment Patterns at the 2025 ESCMID Congress
April 9, 2025
·
8 min read
Drug Development
Assembly Biosciences Doses First Participant in Phase 1b Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate ABI-4334 for the Treatment of Chronic Hepatitis B Virus Infection
Assembly Biosciences, Inc. announced that the first participant has been dosed in the Phase 1b trial of ABI-4334, a next-generation capsid assembly modulator candidate in development for the treatment of chronic hepatitis B virus infection.
June 18, 2024
·
5 min read
Press Releases
Assembly Biosciences Doses First Participant in Phase 1a Clinical Study of Oral Entry Inhibitor Candidate ABI-6250 for Hepatitis Delta Virus
February 26, 2025
·
5 min read
Business
Assembly Biosciences Reports First Quarter 2024 Financial Results and Recent Highlights
Assembly Biosciences, Inc., a biotechnology company developing innovative therapeutics targeting serious viral diseases, reported financial results and recent highlights for the first quarter ended March 31, 2024.
May 8, 2024
·
8 min read
Press Releases
Assembly Biosciences Reports Interim Phase 1b Results from Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate ABI-4334 in Chronic Hepatitis B
December 27, 2024
·
7 min read
Biotech Bay
Assembly Biosciences to Present Data at Upcoming International Herpesvirus Workshop and EASL Congress™ 2024
Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral diseases, today announced that the company will present data from its herpes simplex virus (HSV) and hepatitis D virus (HDV) pipeline programs at upcoming medical congresses.
May 22, 2024
·
6 min read
1 of 5,045
Next
